SeaStar Medical Holding Corporation ICU

FY2025 · ended Dec 31, 2025 · Revenue $1.23M, +814.1% YoY · Filed Mar 25, 2026

SeaStar Medical Holding Corporation (ICU) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.2 million and a net loss of $12.2 million.

Revenue (TTM)
$1.71M
Net income (TTM)
$-13.63M
+7.1% vs year-ago TTM
Operating cash flow (TTM)
$-13.69M
+10.8% vs year-ago TTM
Free cash flow
—
EPS
$-6.63
+78.1% vs prior year
Dividend per share
None
Shares outstanding
3.99M
-54.2% vs prior year
Net cash
$1.25M
FY 2024
Operating margin
-816.6%
FY 2026

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
ICU (Nasdaq), ICUCW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Denver, CO
SEC filer status
, Emerging growth company
SEC CIK
1831868
Former names
LMF Acquisition Opportunities Inc (until Oct 27, 2022)

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$1.2M
$135,000
—
—
—
Operating income
-$12.2M
-$17.8M
-$14.2M
-$11.6M
-$4.4M
Net income
-$12.2M
-$24.8M
-$26.2M
-$12.2M
-$4.6M
Diluted EPS
—
-$6.63
-$30.26
-$1.48
—
Operating cash flow
-$13.6M
-$16.0M
-$10.3M
-$7.8M
-$5.1M
Total assets
$14.2M
$4.7M
$3.5M
$3.0M
$603,000
Total liabilities
$3.7M
$6.8M
$17.4M
$23.8M
$3.4M
Stockholders' equity
$10.4M
-$2.2M
-$13.9M
-$20.8M
-$2.8M
Cash and investments
$12.0M
$1.8M
$176,000
$47,000
$510,000
Total debt
—
$574,000
$4.1M
—
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Other events
Nov 3, 2026 Oct 30, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 5, 2026 Oct 5, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
8-K Current report
Officer or director change
Jul 1, 2026 Jun 25, 2026
8-K/A Amended current report
Officer or director change
Jun 23, 2026 Aug 13, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.